Introducing sense into nonsense in treatments of human genetic diseases

Liat Linde1, Batsheva Kerem

  • 1Department of Genetics, The Life Sciences Institute, Givat Ram Campus, The Hebrew University, Jerusalem 91904, Israel.

Trends in Genetics : TIG
|October 22, 2008
PubMed

Insights

Therapeutic readthrough of premature termination codons (PTCs) aims to restore full-length proteins for genetic diseases. Variable effects highlight the need to understand factors like nonsense-mediated mRNA decay (NMD) for better therapies.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pharmacology

Background:

  • Genetic diseases often result from premature termination codons (PTCs) leading to truncated, non-functional proteins.
  • Approximately one-third of disease-causing alleles feature PTCs, presenting a significant therapeutic target.
  • Readthrough strategies aim to bypass PTCs, enabling the synthesis of full-length proteins.

Purpose of the Study:

  • To investigate therapeutic readthrough approaches for genetic diseases caused by PTCs.
  • To analyze factors influencing variable readthrough efficacy in conditions like cystic fibrosis and Duchenne muscular dystrophy.
  • To explore the role of nonsense-mediated mRNA decay (NMD) in regulating PTC readthrough responses.

Main Methods:

  • Review of existing therapeutic strategies for PTC readthrough.
  • Analysis of case studies focusing on cystic fibrosis and Duchenne muscular dystrophy.
  • Discussion of molecular mechanisms, including NMD, affecting readthrough outcomes.

Main Results:

  • Therapeutic readthrough of PTCs shows promise but exhibits variable efficacy across different diseases and patients.
  • Factors influencing readthrough success include PTC context and the activity of cellular pathways like NMD.
  • Nonsense-mediated mRNA decay (NMD) plays a critical role in determining the cellular response to PTCs.

Conclusions:

  • A deeper understanding of the molecular basis for variable readthrough responses is crucial.
  • Targeting factors that modulate readthrough and NMD could lead to more effective therapies for PTC-associated genetic disorders.
  • Further research is needed to optimize readthrough therapies for widespread clinical application.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...